SEC Form 4 · accession 0001162194-16-000219
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerhard F Burbach
Director
Period of report
Aug 3, 2016
Accepted (ET)
Aug 4, 2016 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Aug 3, 2016 | A | 5,000 | A | — | — | Common Stock | 5,000 | 5,000 | D |
| Stock Option (Right to Buy)F3 | $10.45 | Aug 3, 2016 | A | 5,000 | A | — | Aug 3, 2026 | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F2All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 3, 2017, subject to continued service as a director through the vesting date.
- F31/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 3, 2017.